Rapid-Onset Obesity.pdf (503.12 kB)

Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD): exome sequencing of trios, monozygotic twins and tumours.

Download (503.12 kB)
journal contribution
posted on 12.02.2016, 00:00 by SF Barclay, CM Rand, LA Borch, L Nguyen, PA Gray, WT Gibson, RJ Wilson, PM Gordon, Z Aung, EM Berry-Kravis, D Ize-Ludlow, DE Weese-Mayer, NT Bech-Hansen
BACKGROUND: Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD) is thought to be a genetic disease caused by de novo mutations, though causative mutations have yet to be identified. We searched for de novo coding mutations among a carefully-diagnosed and clinically homogeneous cohort of 35 ROHHAD patients. METHODS: We sequenced the exomes of seven ROHHAD trios, plus tumours from four of these patients and the unaffected monozygotic (MZ) twin of one (discovery cohort), to identify constitutional and somatic de novo sequence variants. We further analyzed this exome data to search for candidate genes under autosomal dominant and recessive models, and to identify structural variations. Candidate genes were tested by exome or Sanger sequencing in a replication cohort of 28 ROHHAD singletons. RESULTS: The analysis of the trio-based exomes found 13 de novo variants. However, no two patients had de novo variants in the same gene, and additional patient exomes and mutation analysis in the replication cohort did not provide strong genetic evidence to implicate any of these sequence variants in ROHHAD. Somatic comparisons revealed no coding differences between any blood and tumour samples, or between the two discordant MZ twins. Neither autosomal dominant nor recessive analysis yielded candidate genes for ROHHAD, and we did not identify any potentially causative structural variations. CONCLUSIONS: Clinical exome sequencing is highly unlikely to be a useful diagnostic test in patients with true ROHHAD. As ROHHAD has a high risk for fatality if not properly managed, it remains imperative to expand the search for non-exomic genetic risk factors, as well as to investigate other possible mechanisms of disease. In so doing, we will be able to confirm objectively the ROHHAD diagnosis and to contribute to our understanding of obesity, respiratory control, hypothalamic function, and autonomic regulation.

Funding

Grant Support HL089742/HL/NHLBI NIH HHS/United States, UL1 TR001422/TR/NCATS NIH HHS/United States, and Canadian Institutes of Health Research/Canada.

History

Publisher Statement

This is the copy of an article published in the Orphanet Journal of Rare Diseases © 2015 BioMed Central Publications. © 2015 Barclay et al.

Publisher

BioMed Central

issn

1750-1172

Issue date

25/08/2015

Exports